Anticancer and Antiinflammatory Effects of Bamboo Salt

Author(s):  
Dr. Xin Zhao
2013 ◽  
Vol 42 (12) ◽  
pp. 1915-1923 ◽  
Author(s):  
Min-Woo Jeong ◽  
Ji-Kang Jeong ◽  
Sin-Jeong Kim ◽  
Kun-Young Park
Keyword(s):  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ilia Beberashvili ◽  
Tamar Cohen-Cesla ◽  
Amin Khatib ◽  
Ramzia Abu Hamad ◽  
Ada Azar ◽  
...  

AbstractDespite experimental evidence of beneficial metabolic, antiatherosclerotic and antiinflammatory effects of the 30 kDa adipokine, adiponectin, maintenance hemodialysis (MHD) patients with high adiponectin blood levels have paradoxically high mortality rates. We aimed to examine the direction of the associations between adiponectin and all-cause and cardiovascular mortality as well as with markers of oxidative stress, inflammation and nutrition in MHD patients with varying degrees of comorbidities. A cohort of 261 MHD patients (mean age 68.6 ± 13.6 years, 38.7% women), grouped according to baseline comorbidity index (CI) and serum adiponectin levels, were followed prospectively for six years. High and low concentrations were established according to median CI and adiponectin levels and cross-classified. Across the four CI-adiponectin categories, the group with low comorbidities and high adiponectin exhibited the best outcomes. Conversely, the high comorbidity group with high adiponectin levels had the lowest survival rate in both all-cause mortality (log rankχ2 = 23.74, p < 0.001) and cardiovascular mortality (log rankχ2 = 34.16, p < 0.001). Further data adjustment for case-mix covariates including fat mass index did not substantially affect these results. In conclusion, the direction of adiponectin’s prognostic associations in MHD patients is inverse in those with few comorbidities and direct in those with many comorbidities.


1980 ◽  
Vol 23 (7) ◽  
pp. 729-734 ◽  
Author(s):  
D. H. Brown ◽  
W. E. Smith ◽  
J. W. Teape ◽  
A. J. Lewis

1994 ◽  
Vol 741 (1 Neuroimmunomo) ◽  
pp. 137-148 ◽  
Author(s):  
J. M. LIPTON ◽  
G. CERIANI ◽  
A. MACALUSO ◽  
D. McCOY ◽  
K. CARNES ◽  
...  

1985 ◽  
Vol 50 (8) ◽  
pp. 1888-1898 ◽  
Author(s):  
Miroslav Protiva ◽  
Zdeněk Šedivý ◽  
Jiří Holubek ◽  
Emil Svátek ◽  
Jiří Němec

Reactions of naphthostyril (I) with primary and secondary amines and titanium tetrachloride afforded cyclic amidines III-IX. Hydrogenation of I on Pd-C resulted in the 6,7,8,8a-tetrahydro derivative X which gave by treatment with sodium amide and 3-dimethylaminopropyl chloride the N-(aminoalkyl) compound XI. Reduction of I and its N-methyl derivative II with sodium amalgam in aqueous sodium hydroxide gave the 2a,3,4,5-tetrahydro derivatives XII and XIII. Reaction of XIII with sodium amide and 3-dimethylaminopropyl chloride afforded the 2a-(aminoalkyl) compound XIV. 1,3,4,5-Tetrahydro-1-benzazepin-2-one (XV) treated with primary amines and titanium tetrachloride gave the amidines XVI-XVIII. 3-Methyl-7,8,9,9a-tetrahydro-1H-benz[d,e]isoquinoline (XIX) was reduced with sodium borohydride to compound XX which was alkylated with propargyl bromide to 1-methyl-2-propargyl-2,3,3a,4,5,6-hexahydro-1H-benz[d,e]isoquinoline (XXI). An attempt to prepare the 2-(2-phenylethyl) analogue by treatment of compound XX with phenylacetyl chloride and by the following reduction with lithium aluminium hydride resulted in the open-chain amine XXII. The lactams I, II, X, and XIII showed some discoordinating, hypothermic, peripheral vasodilating, hyperglycaemic, diuretic and antiinflammatory effects. The amidines III-IX and XVI-XVIII had local anaesthetic, slight hypotensive, antiarrhythmic, peripheral myorelaxant, papaverine-like spasmolytic and thiopental potentiating effects.


2013 ◽  
Vol 16 (1) ◽  
pp. 9-19 ◽  
Author(s):  
Xin Zhao ◽  
So-Young Kim ◽  
Kun-Young Park
Keyword(s):  
Hct 116 ◽  

Sign in / Sign up

Export Citation Format

Share Document